zbh-8k_20191105.htm

0001564590-19-040046.txt : 20191105 0001564590-19-040046.hdr.sgml : 20191105 20191105063222 ACCESSION NUMBER: 0001564590-19-040046 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20191105 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20191105 DATE AS OF CHANGE: 20191105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZIMMER BIOMET HOLDINGS, INC. CENTRAL INDEX KEY: 0001136869 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 134151777 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16407 FILM NUMBER: 191191661 BUSINESS ADDRESS: STREET 1: 345 EAST MAIN STREET CITY: WARSAW STATE: IN ZIP: 46580 BUSINESS PHONE: 5742676131 MAIL ADDRESS: STREET 1: 345 EAST MAIN STREET CITY: WARSAW STATE: IN ZIP: 46580 FORMER COMPANY: FORMER CONFORMED NAME: ZIMMER HOLDINGS INC DATE OF NAME CHANGE: 20010315 8-K 1 zbh-8k_20191105.htm 8-K zbh-8k_20191105.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 5, 2019

ZIMMER BIOMET HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware	001-16407	13-4151777
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

345 East Main Street

Warsaw, Indiana 46580

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (574) 267-6131

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value	ZBH	New York Stock Exchange
1.414% Notes due 2022	ZBH 22A	New York Stock Exchange
2.425% Notes due 2026	ZBH 26	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Item 2.02Results of Operations and Financial Condition.

On November 5, 2019, Zimmer Biomet Holdings, Inc. (the “Company”) issued a press release reporting its financial results for the quarter ended September 30, 2019. The press release is attached hereto as Exhibit 99.1 and the information set forth therein is incorporated herein by reference and constitutes a part of this report.

The information contained in Item 2.02 of this report, including Exhibit 99.1 hereto, is being furnished and shall not be deemed to be “filed” with the Securities and Exchange Commission for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section and is not incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01

Financial Statements and Exhibits.

(d)

Exhibits

EXHIBIT INDEX
Exhibit No.		Description
99.1 104		Press release dated November 5, 2019 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: November 5, 2019

	ZIMMER BIOMET HOLDINGS, INC.

	By:	/s/ Chad F. Phipps
	Name:	Chad F. Phipps
	Title:	Senior Vice President, General Counsel and Secretary

EX-99.1 2 zbh-ex991_6.htm EX-99.1 zbh-ex991_6.htm

345 E. Main St.
Warsaw, IN 46580
www.zimmerbiomet.com	Exhibit 99.1

Media	Investors
Wendy Wilson	Cole Lannum, CFA
(574) 373-3798	(508) 409-9366
wendy.wilson@zimmerbiomet.com	cole.lannum@zimmerbiomet.com

	Barb Goslee
	(574) 371-9449
	barb.goslee@zimmerbiomet.com

Zimmer Biomet Announces

Third Quarter 2019 Financial Results

•

Net sales of $1.892 billion for the third quarter represent an increase of 3.0% over the prior year period; an increase of 3.9% on a constant currency basis

•

Diluted earnings per share for the third quarter were $2.08 and adjusted diluted earnings per share were $1.77

•

The Company’s guidance remains unchanged

(WARSAW, IN) November 5, 2019 — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2019. The Company reported third quarter net sales of $1.892 billion, an increase of 3.0% over the prior year period, and an increase of 3.9% on a constant currency basis. Diluted earnings per share for the third quarter were $2.08, an increase of 163% over the prior year period. Third quarter adjusted diluted earnings per share were $1.77, an increase of 8.6% over the prior year period. Net earnings for the third quarter were $431 million and $366 million on an adjusted basis.

“Our global team delivered strong results this quarter, fueled by a clear focus on our strategic priorities and key new product introductions,” said Bryan Hanson, President and CEO of Zimmer Biomet. “I’m excited by the momentum across the organization and am grateful for the commitment and winning spirit from our team members around the world.”

Page 1 of 24

Geographic and Product Category Sales

The following sales tables provide results by geography and product category for the three and nine month periods ended September 30, 2019, as well as the percentage change compared to the prior year periods, on both a reported basis and a constant currency basis.

NET SALES - THREE MONTHS ENDED SEPTEMBER 30, 2019
(in millions, unaudited)


							Constant
	Net						Currency
	Sales		% Change				% Change
Geographic Results
Americas	$	1,179		2.2		%		2.3		%
EMEA		375		0.7				4.8
Asia Pacific		338		8.9				8.8
Total	$	1,892		3.0		%		3.9		%
Product Categories
Knees
Americas	$	399		3.8		%		3.8		%
EMEA		135		0.7				4.8
Asia Pacific		118		7.8				8.5
Total		652		3.8				4.9
Hips
Americas		249		3.7				3.8
EMEA		109		1.1				5.1
Asia Pacific		102		5.4				4.7
Total		460		3.5				4.3
S.E.T *		438		5.6				6.2
Spine & CMF**		181		(1.9	)			(1.3	)
Dental		94		2.1				3.0
Other		67		(7.0	)			(6.1	)
Total	$	1,892		3.0		%		3.9		%


^*Surgical, Sports Medicine, Extremities and Trauma
** Craniomaxillofacial

Page 2 of 24

NET SALES - NINE MONTHS ENDED SEPTEMBER 30, 2019
(in millions, unaudited)


							Constant
	Net						Currency
	Sales		% Change				% Change
Geographic Results
Americas	$	3,588		0.3		%		0.5		%
EMEA		1,277		(3.8	)			2.5
Asia Pacific		992		3.6				6.3
Total	$	5,857		(0.1	)	%		1.9		%
Product Categories
Knees
Americas	$	1,223		1.1		%		1.2		%
EMEA		475		(4.0	)			2.6
Asia Pacific		352		3.5				6.9
Total		2,050		0.3				2.5
Hips
Americas		749		1.6				1.8
EMEA		368		(4.1	)			2.1
Asia Pacific		307		1.4				3.6
Total		1,424		-				2.3
S.E.T *		1,322		2.4				4.0
Spine & CMF**		550		(2.8	)			(1.6	)
Dental		305		(0.5	)			1.4
Other		206		(10.6	)			(8.9	)
Total	$	5,857		(0.1	)	%		1.9		%


^*Surgical, Sports Medicine, Extremities and Trauma
** Craniomaxillofacial

Cash Flow and Balance Sheet

Operating cash flow for the third quarter was $578 million and free cash flow was $425 million. In the third quarter, the Company paid down $330 million of debt, paid $49 million in dividends and declared a dividend of $0.24 per share.

Guidance

The Company’s prior guidance remains unchanged.

Page 3 of 24

Conference Call

The Company will conduct its third quarter 2019 investor conference call today, November 5, 2019, at 8:30 a.m. Eastern Time. The audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. It will be archived for replay following the conference call.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.

We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

Website Information

We routinely post important information for investors on our website, www.zimmerbiomet.com, in the “Investor Relations” section. We use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investor Relations section of our website, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

Note on Non-GAAP Financial Measures

This press release includes non-GAAP financial measures that differ from financial measures calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These non-GAAP financial measures may not be comparable to similar measures reported by other companies and should be considered in addition to, and not as a substitute for, or superior to, other measures prepared in accordance with GAAP.

Page 4 of 24

Sales change information for the three and nine month periods ended September 30, 2019 is presented on a GAAP (reported) basis and on a constant currency basis. Constant currency percentage changes exclude the effects of foreign currency exchange rates. They are calculated by translating current and prior-period sales at the same predetermined exchange rate. The translated results are then used to determine year-over-year percentage increases or decreases.

Net earnings and diluted earnings per share for the three and nine month periods ended September 30, 2019 are presented on a GAAP (reported) basis and on an adjusted basis. Adjusted earnings and adjusted diluted earnings per share exclude the effects of certain inventory and manufacturing-related charges, including charges to terminate a raw material supply agreement and to discontinue certain product lines; intangible asset amortization; intangible asset impairment; acquisition, integration and related gains and expenses; quality remediation expenses; certain litigation gains and charges; expenses to comply with the new European Union Medical Device Regulation; other charges; any related effects on our income tax provision associated with these items, the effect of Switzerland tax reform and other certain tax adjustments.

Free cash flow is an additional non-GAAP measure that is presented in this press release. Free cash flow is computed by deducting additions to instruments and other property, plant and equipment from net cash provided by operating activities.

Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in this press release. This press release also contains supplemental reconciliations of additional non-GAAP financial measures that the Company presents in other contexts. These additional non-GAAP financial measures are computed from the most directly comparable GAAP financial measure as indicated in the applicable reconciliation.

Management uses non-GAAP financial measures internally to evaluate the performance of the business. Additionally, management believes these non-GAAP measures provide meaningful incremental information to investors to consider when evaluating the performance of the Company. Management believes these measures offer the ability to make period-to-period comparisons that are not impacted by certain items that can cause dramatic changes in reported income but that do not impact the fundamentals of our operations. The non-GAAP measures enable the evaluation of operating results and trend analysis by allowing a reader to better identify operating trends that may otherwise be masked or distorted by these types of items that are excluded from the non-GAAP measures. In addition, constant currency sales changes, adjusted operating profit, adjusted diluted earnings per share and free cash flow are used as performance metrics in our incentive compensation programs.

Page 5 of 24

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of federal securities laws, including, among others, statements regarding sales and earnings guidance and any statements about our expectations, plans, strategies or prospects. We generally use the words “may,” “will,” “expects,” “believes,” “anticipates,” “plans,” “estimates,” “projects,” “assumes,” “guides,” “targets,” “forecasts,” “sees,” “seeks,” “should,” “could,” “would,” “predicts,” “potential,” “strategy,” “future,” “opportunity,” “work toward,” “intends,” “guidance,” “confidence,” “positioned,” “look forward to” and similar expressions to identify forward-looking statements. All statements other than statements of historical or current fact are, or may be deemed to be, forward-looking statements. Such statements are based upon the current beliefs, expectations and assumptions of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially from the forward-looking statements. These risks, uncertainties and changes in circumstances include, but are not limited to: the possibility that the anticipated synergies and other benefits from mergers and acquisitions will not be realized, or will not be realized within the expected time periods; the risks and uncertainties related to our ability to successfully integrate the operations, products, employees and distributors of acquired companies; the effect of the potential disruption of management’s attention from ongoing business operations due to integration matters related to mergers and acquisitions; the effect of mergers and acquisitions on our relationships with customers, vendors and lenders and on our operating results and businesses generally; compliance with the Deferred Prosecution Agreement entered into in January 2017; the success of our quality and operational excellence initiatives, including ongoing quality remediation efforts at our Warsaw North Campus facility; challenges relating to changes in and compliance with governmental laws and regulations affecting our U.S. and international businesses, including regulations of the U.S. Food and Drug Administration (FDA) and foreign government regulators, such as more stringent requirements for regulatory clearance of products; the ability to remediate matters identified in any inspectional observations or warning letters issued by the FDA, while continuing to satisfy the demand for our products; the outcome of government investigations; competition; pricing pressures; changes in customer demand for our products and services caused by demographic changes or other factors; the impact of healthcare reform measures, including the impact of the U.S. excise tax on medical devices if such tax is not further suspended or repealed; reductions in reimbursement levels by third-party payors and cost containment efforts of healthcare purchasing organizations; dependence on new product development, technological advances and innovation; shifts in the product category or regional sales mix of our products and services; supply and prices of raw materials and products; control of costs and expenses; the ability to obtain and maintain adequate intellectual property protection; the ability to form and implement alliances; changes in tax obligations arising from tax reform measures, including European Union rules on state aid, or examinations by tax authorities; product liability and

Page 6 of 24

intellectual property litigation losses; the ability to retain the independent agents and distributors who market our products; dependence on a limited number of suppliers for key raw materials and outsourced activities; changes in general industry and market conditions, including domestic and international growth rates; changes in general domestic and international economic conditions, including interest rate and currency exchange rate fluctuations; and the impact of the ongoing financial and political uncertainty on countries in the Euro zone on the ability to collect accounts receivable in affected countries. For a further list and description of such risks and uncertainties, see our reports filed with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2018 and our Quarterly Report on Form 10-Q for the quarter ended June 30, 2019. Copies of these filings, as well as subsequent filings, are available online at www.sec.gov, www.zimmerbiomet.com or on request from us. Forward-looking statements speak only as of the date they are made, and we expressly disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers of this press release are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary note is applicable to all forward-looking statements contained in this press release.

###

Page 7 of 24


ZIMMER BIOMET HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019 and 2018
(in millions, except per share amounts, unaudited)

	2019			2018
Net Sales	$	1,892.4		$	1,836.7
Cost of products sold, excluding intangible asset amortization		535.7			529.0
Intangible asset amortization		146.6			147.6
Research and development		114.4			95.7
Selling, general and administrative		830.1			787.7
Intangible asset impairment		-			3.8
Acquisition, integration and related		(0.9	)		17.4
Quality remediation		20.7			32.2
Operating expenses		1,646.6			1,613.4
Operating Profit		245.8			223.3
Other expense, net		(4.4	)		(2.2	)
Interest expense, net		(56.8	)		(67.5	)
Earnings before income taxes		184.6			153.6
Benefit for income taxes		(247.4	)		(8.5	)
Net Earnings		432.0			162.1
Less: Net earnings (loss) attributable to noncontrolling interest		0.9			(0.1	)
Net Earnings of Zimmer Biomet Holdings, Inc.	$	431.1		$	162.2
Earnings Per Common Share
Basic	$	2.10		$	0.80
Diluted	$	2.08		$	0.79
Weighted Average Common Shares Outstanding
Basic		205.3			203.7
Diluted		207.0			205.4

Page 8 of 24


ZIMMER BIOMET HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 and 2018
(in millions, except per share amounts, unaudited)

	2019			2018
Net Sales	$	5,856.5		$	5,861.9
Cost of products sold, excluding intangible asset amortization		1,670.4			1,688.5
Intangible asset amortization		436.9			447.9
Research and development		328.2			290.5
Selling, general and administrative		2,466.8			2,380.7
Intangible asset impairment		70.1			3.8
Acquisition, integration and related		20.3			113.9
Quality remediation		63.1			112.3
Operating expenses		5,055.8			5,037.6
Operating Profit		800.7			824.3
Other expense, net		(9.6	)		(8.7	)
Interest expense, net		(174.5	)		(220.8	)
Earnings before income taxes		616.6			594.8
(Benefit) provision for income taxes		(193.5	)		71.6
Net Earnings		810.1			523.2
Less: Net (loss) earnings attributable to noncontrolling interest		(0.8	)		1.3
Net Earnings of Zimmer Biomet Holdings, Inc.	$	810.9		$	521.9
Earnings Per Common Share
Basic	$	3.96		$	2.57
Diluted	$	3.93		$	2.55
Weighted Average Common Shares Outstanding
Basic		204.8			203.3
Diluted		206.3			204.9

Page 9 of 24

ZIMMER BIOMET HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions, unaudited)

	September 30,		December 31,
	2019		2018
Assets
Cash and cash equivalents	$	512.5	$	542.8
Receivables, net		1,150.8		1,275.8
Inventories		2,362.3		2,256.5
Other current assets		375.9		352.3
Total current assets		4,401.5		4,427.4
Property, plant and equipment, net		2,055.3		2,015.4
Goodwill		9,544.9		9,594.4
Intangible assets, net		7,339.9		7,684.6
Other assets		973.6		405.0
Total Assets	$	24,315.2	$	24,126.8
Liabilities and Stockholders' Equity
Current liabilities	$	1,773.9	$	1,896.3
Current portion of long-term debt		2,000.0		525.0
Other long-term liabilities		2,109.9		2,015.7
Long-term debt		6,345.9		8,413.7
Stockholders' equity		12,085.5		11,276.1
Total Liabilities and Stockholders' Equity	$	24,315.2	$	24,126.8

Page 10 of 24

ZIMMER BIOMET HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 and 2018
(in millions, unaudited)

	2019			2018
Cash flows provided by (used in) operating activities
Net earnings	$	810.1		$	523.2
Depreciation and amortization		752.2			785.7
Share-based compensation		61.6			45.3
Intangible asset impairment		70.1			3.8
Changes in operating assets and liabilities, net of acquired assets and liabilities
Income taxes		(356.3	)		(58.3	)
Receivables		109.5			237.4
Inventories		(106.0	)		(165.2	)
Accounts payable and accrued expenses		(162.7	)		23.6
Other assets and liabilities		(16.0	)		(27.6	)
Net cash provided by operating activities ⁽¹⁾		1,162.5			1,367.9
Cash flows provided by (used in) investing activities
Additions to instruments		(239.5	)		(203.7	)
Additions to other property, plant and equipment		(155.3	)		(115.2	)
Net investment hedge settlements		37.5			-
Acquisition of intellectual property rights		(197.6	)		-
Investments in other assets		(36.4	)		(15.3	)
Net cash used in investing activities		(591.3	)		(334.2	)
Cash flows provided by (used in) financing activities
Proceeds from senior notes		-			749.5
Proceeds from multicurrency revolving facility		-			400.0
Payments on multicurrency revolving facility		-			(400.0	)
Redemption of senior notes		-			(1,150.0	)
Proceeds from term loans		200.0			-
Payments on term loans		(750.0	)		(500.0	)
Net payments on other debt		(5.0	)		(3.9	)
Dividends paid to stockholders		(147.3	)		(146.2	)
Proceeds from employee stock compensation plans		125.9			103.4
Net cash flows from unremitted collections from factoring programs		(15.4	)		(54.6	)
Business combination contingent consideration payments		-			(16.7	)
Other financing activities		(5.4	)		(8.2	)
Net cash used in financing activities		(597.2	)		(1,026.7	)
Effect of exchange rates on cash and cash equivalents		(4.3	)		(6.8	)
(Decrease) increase in cash and cash equivalents		(30.3	)		0.2
Cash and cash equivalents, beginning of period		542.8			524.4
Cash and cash equivalents, end of period	$	512.5		$	524.6

⁽¹⁾ 2019 reflects approximately $168 million paid related to a patent litigation matter

Page 11 of 24

ZIMMER BIOMET HOLDINGS, INC.
NET SALES BY GEOGRAPHY
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019 and 2018
(in millions, unaudited)

	Three Months Ended September 30,
	2019		2018		% Inc			Volume / Mix			Price				Foreign Exchange
Americas	$	1,179.2	$	1,153.6		2.2	%		5.7	%		(3.4	)	%		(0.1	)	%
EMEA		374.6		372.1		0.7			6.7			(1.9	)			(4.1	)
Asia Pacific		338.6		311.0		8.9			11.2			(2.4	)			0.1
Total	$	1,892.4	$	1,836.7		3.0	%		6.8	%		(2.9	)	%		(0.9	)	%

ZIMMER BIOMET HOLDINGS, INC.
NET SALES BY PRODUCT CATEGORY
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019 and 2018
(in millions, unaudited)

	Three Months Ended September 30,
	2019		2018		% Inc / (Dec)				Volume / Mix			Price				Foreign Exchange
Knees	$	651.9	$	627.9		3.8		%		7.5	%		(2.6	)	%		(1.1	)	%
Hips		460.2		444.8		3.5				6.9			(2.6	)			(0.8	)
S.E.T		437.7		414.6		5.6				8.2			(2.0	)			(0.6	)
Spine & CMF		181.3		184.9		(1.9	)			1.3			(2.6	)			(0.6	)
Dental		94.2		92.3		2.1				3.9			(0.9	)			(0.9	)
Other		67.1		72.2		(7.0	)			10.3			(16.4	)			(0.9	)
Total	$	1,892.4	$	1,836.7		3.0		%		6.8	%		(2.9	)	%		(0.9	)	%

Page 12 of 24

ZIMMER BIOMET HOLDINGS, INC.
NET SALES BY GEOGRAPHY
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 and 2018
(in millions, unaudited)

	Nine Months Ended September 30,
	2019		2018		% Inc / (Dec)				Volume / Mix			Price				Foreign Exchange
Americas	$	3,587.6	$	3,578.0		0.3		%		3.6	%		(3.1	)	%		(0.2	)	%
EMEA		1,276.5		1,326.3		(3.8	)			4.6			(2.1	)			(6.3	)
Asia Pacific		992.4		957.6		3.6				8.5			(2.2	)			(2.7	)
Total	$	5,856.5	$	5,861.9		(0.1	)	%		4.6	%		(2.7	)	%		(2.0	)	%

ZIMMER BIOMET HOLDINGS, INC.
NET SALES BY PRODUCT CATEGORY
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 and 2018
(in millions, unaudited)

	Nine Months Ended September 30,
	2019		2018		% Inc / (Dec)				Volume / Mix				Price				Foreign Exchange
Knees	$	2,049.5	$	2,044.2		0.3		%		5.5		%		(3.0	)	%		(2.2	)	%
Hips		1,423.8		1,423.7		-				5.3				(3.0	)			(2.3	)
S.E.T		1,322.0		1,290.7		2.4				5.5				(1.5	)			(1.6	)
Spine & CMF		550.0		566.2		(2.8	)			1.0				(2.6	)			(1.2	)
Dental		305.2		306.8		(0.5	)			2.7				(1.3	)			(1.9	)
Other		206.0		230.3		(10.6	)			(1.2	)			(7.7	)			(1.7	)
Total	$	5,856.5	$	5,861.9		(0.1	)	%		4.6		%		(2.7	)	%		(2.0	)	%

Page 13 of 24

ZIMMER BIOMET HOLDINGS, INC.
RECONCILIATION OF REPORTED NET SALES % CHANGE TO
CONSTANT CURRENCY % CHANGE
(unaudited)


	For the Three Months Ended
	September 30, 2019
					Foreign				Constant
					Exchange				Currency
	% Change				Impact				% Change
Geographic Results
Americas		2.2		%		(0.1	)	%		2.3		%
EMEA		0.7				(4.1	)			4.8
Asia Pacific		8.9				0.1				8.8
Total		3.0		%		(0.9	)	%		3.9		%
Product Categories
Knees
Americas		3.8		%		-		%		3.8		%
EMEA		0.7				(4.1	)			4.8
Asia Pacific		7.8				(0.7	)			8.5
Total		3.8				(1.1	)			4.9
Hips
Americas		3.7				(0.1	)			3.8
EMEA		1.1				(4.0	)			5.1
Asia Pacific		5.4				0.7				4.7
Total		3.5				(0.8	)			4.3
S.E.T		5.6				(0.6	)			6.2
Spine & CMF		(1.9	)			(0.6	)			(1.3	)
Dental		2.1				(0.9	)			3.0
Other		(7.0	)			(0.9	)			(6.1	)
Total		3.0		%		(0.9	)	%		3.9		%

Page 14 of 24

ZIMMER BIOMET HOLDINGS, INC.
RECONCILIATION OF REPORTED NET SALES % CHANGE TO
CONSTANT CURRENCY % CHANGE
(unaudited)


	For the Nine Months Ended
	September 30, 2019
					Foreign				Constant
					Exchange				Currency
	% Change				Impact				% Change
Geographic Results
Americas		0.3		%		(0.2	)	%		0.5		%
EMEA		(3.8	)			(6.3	)			2.5
Asia Pacific		3.6				(2.7	)			6.3
Total		(0.1	)	%		(2.0	)	%		1.9		%
Product Categories
Knees
Americas		1.1		%		(0.1	)	%		1.2		%
EMEA		(4.0	)			(6.6	)			2.6
Asia Pacific		3.5				(3.4	)			6.9
Total		0.3				(2.2	)			2.5
Hips
Americas		1.6				(0.2	)			1.8
EMEA		(4.1	)			(6.2	)			2.1
Asia Pacific		1.4				(2.2	)			3.6
Total		-				(2.3	)			2.3
S.E.T		2.4				(1.6	)			4.0
Spine & CMF		(2.8	)			(1.2	)			(1.6	)
Dental		(0.5	)			(1.9	)			1.4
Other		(10.6	)			(1.7	)			(8.9	)
Total		(0.1	)	%		(2.0	)	%		1.9		%

Page 15 of 24

ZIMMER BIOMET HOLDINGS, INC.
RECONCILIATION OF REPORTED TO ADJUSTED RESULTS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019 and 2018
(in millions, unaudited)


FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2019
	Cost of products sold, excluding intangible asset amortization			Intangible asset amortization			Research and development			Selling, general and administrative			Acquisition, integration and related			Quality remediation			Benefit for income taxes			Net Loss attributable to noncontrolling interest		Net Earnings of Zimmer Biomet Holdings, Inc.			Diluted earnings per common share
As Reported	$	535.7		$	146.6		$	114.4		$	830.1		$	(0.9	)	$	20.7		$	(247.4	)	$	0.9	$	431.1		$	2.08
Inventory and manufacturing-related charges⁽¹⁾		(11.6	)		-			-			-			-			-			6.8			-		4.8			0.02
Intangible asset amortization⁽²⁾		-			(146.6	)		-			-			-			-			27.0			-		119.6			0.58
Acquisition, integration and related⁽⁴⁾		-			-			-			-			0.9			-			(0.1	)		-		(0.8	)		-
Quality remediation⁽⁵⁾		(0.8	)		-			-			-			-			(20.7	)		4.8			-		16.7			0.08
Litigation⁽⁶⁾		-			-			-			(42.8	)		-			-			8.7			-		34.1			0.16
European Union Medical Device Regulation⁽⁸⁾		-			-			(11.4	)		-			-			-			2.1			-		9.3			0.05
Other charges⁽⁹⁾		-			-			-			(22.2	)		-			-			5.5			0.1		16.6			0.08
Switzerland tax reform⁽¹⁰⁾		-			-			-			-			-			-			263.8			-		(263.8	)		(1.27	)
Other certain tax adjustments⁽¹¹⁾		-			-			-			-			-			-			1.2			-		(1.2	)		(0.01	)
As Adjusted	$	523.3		$	-		$	103.0		$	765.1		$	-		$	-		$	72.4		$	1.0	$	366.4		$	1.77

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2018
	Cost of products sold, excluding intangible asset amortization			Intangible asset amortization			Selling, general and administrative			Intangible asset impairment			Acquisition, integration and related			Quality remediation			Other expense, net			Benefit for income taxes			Net Earnings of Zimmer Biomet Holdings, Inc.			Diluted earnings per common share
As Reported	$	529.0		$	147.6		$	787.7		$	3.8		$	17.4		$	32.2		$	(2.2	)	$	(8.5	)	$	162.2		$	0.79
Inventory and manufacturing-related charges⁽¹⁾		(5.0	)		-			-			-			-			-			-			18.4			(13.4	)		(0.07	)
Intangible asset amortization⁽²⁾		-			(147.6	)		-			-			-			-			-			19.7			127.9			0.62
Intangible asset impairment⁽³⁾		-			-			-			(3.8	)		-			-			-			0.9			2.9			0.01
Acquisition, integration and related⁽⁴⁾		-			-			-			-			(17.4	)		-			-			7.6			9.8			0.05
Quality remediation⁽⁵⁾		(2.0	)		-			-			-			-			(32.2	)		-			4.9			29.3			0.14
Litigation⁽⁶⁾		-			-			(14.0	)		-			-			-			-			(5.9	)		19.9			0.10
European Union Medical Device Regulation⁽⁸⁾		-			-			(0.8	)					-			-			-			-			0.8			-
Other charges⁽⁹⁾		-			-			(24.9	)		-			-			-			(0.7	)		8.5			15.7			0.09
Other certain tax adjustments⁽¹¹⁾		-			-			-			-			-			-			-			20.5			(20.5	)		(0.10	)
As Adjusted	$	522.0		$	-		$	748.0		$	-		$	-		$	-		$	(2.9	)	$	66.1		$	334.6		$	1.63

Page 16 of 24

ZIMMER BIOMET HOLDINGS, INC.
RECONCILIATION OF REPORTED TO ADJUSTED RESULTS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 and 2018
(in millions, unaudited)


FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019
	Cost of products sold, excluding intangible asset amortization			Intangible asset amortization			Research and development			Selling, general and administrative			Intangible asset impairment			Acquisition, integration and related			Quality remediation			Benefit for income taxes			Net Loss attributable to noncontrolling interest			Net Earnings of Zimmer Biomet Holdings, Inc.			Diluted earnings per common share
As Reported	$	1,670.4		$	436.9		$	328.2		$	2,466.8		$	70.1		$	20.3		$	63.1		$	(193.5	)	$	(0.8	)	$	810.9		$	3.93
Inventory and manufacturing-related charges⁽¹⁾		(47.7	)		-			-			-			-			-			-			19.8			-			27.9			0.14
Intangible asset amortization⁽²⁾		-			(436.9	)		-			-			-			-			-			85.0			-			351.9			1.71
Intangible asset impairment⁽³⁾		-			-			-			-			(70.1	)		-			-			5.5			-			64.6			0.31
Acquisition, integration and related⁽⁴⁾		-			-			-			-			-			(20.3	)		-			5.2			-			15.1			0.07
Quality remediation⁽⁵⁾		(1.5	)		-			-			-			-			-			(63.1	)		14.9			-			49.7			0.24
Litigation⁽⁶⁾		-			-			-			(48.0	)		-			-			-			7.9			-			40.1			0.19
Litigation settlement gain⁽⁷⁾		-			-			-			23.5			-			-			-			(5.2	)		-			(18.3	)		(0.09	)
European Union Medical Device Regulation⁽⁸⁾		-			-			(18.1	)		-			-			-			-			3.2			-			14.9			0.07
Other charges⁽⁹⁾		-			-			(4.3	)		(84.0	)		-			-			-			19.1			1.3			67.9			0.33
Switzerland tax reform⁽¹⁰⁾		-			-			-			-			-			-			-			263.8			-			(263.8	)		(1.27	)
Other certain tax adjustments⁽¹¹⁾		-			-			-			-			-			-			-			12.6			-			(12.6	)		(0.06	)
As Adjusted	$	1,621.2		$	-		$	305.8		$	2,358.3		$	-		$	-		$	-		$	238.3		$	0.5		$	1,148.3		$	5.57

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2018
	Cost of products sold, excluding intangible asset amortization			Intangible asset amortization			Selling, general and administrative			Intangible asset impairment			Acquisition, integration and related			Quality remediation			Other expense, net			Provision for income taxes			Net Earnings of Zimmer Biomet Holdings, Inc.			Diluted earnings per common share
As Reported	$	1,688.5		$	447.9		$	2,380.7		$	3.8		$	113.9		$	112.3		$	(8.7	)	$	71.6		$	521.9		$	2.55
Inventory step-up and other inventory and manufacturing-related charges⁽¹⁾		(24.7	)		-			-			-			-			-			-			9.9			14.8			0.07
Intangible asset amortization⁽²⁾		-			(447.9	)		-			-			-			-			-			80.1			367.8			1.80
Intangible asset impairment⁽³⁾		-			-			-			(3.8	)		-			-			-			0.9			2.9			0.01
Acquisition, integration and related⁽⁴⁾		-			-			-			-			(113.9	)		-			-			24.2			89.7			0.44
Quality remediation⁽⁵⁾		(13.5	)		-			-			-			-			(112.3	)		-			24.8			101.0			0.49
Litigation⁽⁶⁾		-			-			(15.5	)		-			-			-			-			(5.2	)		20.7			0.10
European Union Medical Device Regulation⁽⁸⁾		-			-			(1.6	)		-			-			-			-			0.1			1.5			0.01
Other charges⁽⁹⁾		-			-			(46.8	)		-			-			-			(0.7	)		14.7			31.4			0.15
Other certain tax adjustments⁽¹¹⁾		-			-			-			-			-			-			-			34.2			(34.2	)		(0.17	)
As Adjusted	$	1,650.3		$	-		$	2,316.8		$	-		$	-		$	-		$	(9.4	)	$	255.3		$	1,117.5		$	5.45

⁽¹⁾

In the 2019 periods, inventory and manufacturing-related charges include a $20.8 million charge incurred to terminate a raw material supply agreement recognized in the second quarter, excess and obsolete inventory charges on certain product lines we intend to discontinue and other inventory and manufacturing-related charges. The 2018 charges primarily relate to the excess and obsolete inventory charges on certain product lines we intend to discontinue and other inventory and manufacturing-related charges. The excess and obsolete inventory charges on certain product lines are driven by acquisitions where there are competing product lines and we have plans to discontinue one of the competing product lines.

Page 17 of 24

⁽²⁾

We exclude intangible asset amortization from our non-GAAP financial measures because we internally assess our performance against our peers without this amortization. Due to various levels of acquisitions among our peers, intangible asset amortization can vary significantly from company to company.

⁽³⁾	In the second quarter of 2019 and third quarter of 2018, we recognized $70.1 million and $3.8 million, respectively, of in-process research and development (“IPR&D”) intangible asset impairment due to the termination of certain IPR&D projects.

⁽⁴⁾

The acquisition, integration and related gains and expenses we have excluded from our non-GAAP financial measures resulted from our merger with Biomet in 2015 and other various acquisitions. The acquisition, integration and related gains and expenses include the following types of gains and expenses:

^•

Consulting and professional fees related to third-party integration consulting performed in a variety of areas, such as tax, compliance, logistics and human resources, and legal fees related to the consummation of mergers and acquisitions.

^•

Employee termination benefits related to terminating employees with overlapping responsibilities in various areas of our business.

^•

Dedicated project personnel expenses which include the salary, benefits, travel expenses and other costs directly associated with employees who are 100 percent dedicated to our integration of acquired businesses and employees who have been notified of termination, but are continuing to work on transferring their responsibilities.

^•

Contract termination expenses related to terminated contracts, primarily with sales agents and distribution agreements.

^•

Other various expenses to relocate facilities, integrate information technology, losses incurred on assets resulting from the applicable acquisition, and other various expenses.

⁽⁵⁾

We are addressing inspectional observations on Form 483 and a Warning Letter issued by the U.S. Food and Drug Administration (“FDA”) following its inspections of our Warsaw North Campus facility, among other matters. This quality remediation has required us to devote significant financial resources and is for a discrete period of time. The majority of the expenses are related to consultants who are helping us to update previous documents and redesign certain processes.

⁽⁶⁾

We are involved in routine patent litigation, product liability litigation, commercial litigation and other various litigation matters. We review litigation matters from both a qualitative and quantitative perspective to determine if excluding the losses or gains will provide our investors with useful incremental information. Litigation matters can vary in their characteristics, frequency and significance to our operating results. The litigation charges and gains excluded from our non-GAAP financial measures in the periods presented relate to product liability matters where we have received numerous claims on specific products and commercial litigation related to a common matter in multiple jurisdictions. In regards to the product liability matters, due to the complexities involved and claims filed in multiple districts, the expenses associated with these matters are significant to our operating results. Once the litigation matter has been excluded from our non-GAAP financial measures in a particular period, any additional expenses or gains from changes in estimates are also excluded, even if they are not significant, to ensure consistency in our non-GAAP financial measures from period-to-period.

⁽⁷⁾	In the first quarter of 2019, we settled a patent infringement lawsuit out of court, and the other party agreed to pay us an upfront, lump-sum amount for a non-exclusive license to the patent.

⁽⁸⁾

The European Union Medical Device Regulation imposes significant additional premarket and postmarket requirements. The new regulations provide a transition period until May 2020 for currently-approved medical devices to meet the additional requirements. For certain devices, this transition period can be extended until May 2024. We are excluding from our non-GAAP financial measures the incremental costs incurred to establish initial compliance with the regulations related to our currently-approved medical devices. The incremental costs primarily include third-party consulting necessary to supplement our internal resources.

⁽⁹⁾

We have incurred other various expenses from specific events or projects that we consider highly variable or that have a significant impact to our operating results that we have excluded from our non-GAAP measures. These include costs related to legal entity, distribution and manufacturing restructuring as well as our costs of complying with our Deferred Prosecution Agreement (“DPA”) with the U.S. government related to certain Foreign Corrupt Practices Act matters involving Biomet and certain of its subsidiaries. Under the DPA, which has a three-year term, we are subject to oversight by an independent compliance monitor, which monitorship commenced in August 2017. The excluded costs include the fees paid to the independent compliance monitor and to external legal counsel assisting in the matter.

⁽¹⁰⁾	Switzerland passed the Federal Act on Tax Reform and AHV Financing (TRAF), effective January 1, 2020. Certain provisions of the TRAF were enacted in the third quarter of 2019, resulting in provisional adjustments to our deferred taxes, generating a net tax benefit.

Page 18 of 24

⁽¹¹⁾

Other certain tax adjustments relate to various discrete tax period adjustments, including changes in tax rates on deferred tax liabilities recorded on intangible assets recognized in acquisition-related accounting and adjustments from internal restructuring transactions that provide us access to offshore funds in a tax efficient manner.

Page 19 of 24

ZIMMER BIOMET HOLDINGS, INC.
RECONCILIATION OF NET CASH PROVIDED BY OPERATING
ACTIVITIES TO FREE CASH FLOW
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2019 and 2018
(in millions, unaudited)


	Three Months Ended September 30,						Nine Months Ended September 30,
	2019			2018			2019			2018
Net cash provided by operating activities	$	577.9		$	484.1		$	1,162.5		$	1,367.9
Additions to instruments		(94.7	)		(77.6	)		(239.5	)		(203.7	)
Additions to other property, plant and equipment		(58.6	)		(61.5	)		(155.3	)		(115.2	)
Free cash flow	$	424.6		$	345.0		$	767.7		$	1,049.0

Page 20 of 24

ZIMMER BIOMET HOLDINGS, INC.
RECONCILIATION OF GROSS PROFIT & MARGIN TO ADJUSTED GROSS
PROFIT & MARGIN
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2019 and 2018
(in millions, unaudited)


	Three Months Ended September 30,						Nine Months Ended September 30,
	2019			2018			2019			2018
Net Sales	$	1,892.4		$	1,836.7		$	5,856.5		$	5,861.9
Cost of products sold, excluding intangible asset amortization		535.7			529.0			1,670.4			1,688.5
Intangible asset amortization		146.6			147.6			436.9			447.9
Gross Profit	$	1,210.1		$	1,160.1		$	3,749.2		$	3,725.5

Inventory and manufacturing-related charges		11.6			5.0			47.7			24.7
Quality remediation		0.8			2.0			1.5			13.5
Intangible asset amortization		146.6			147.6			436.9			447.9
Adjusted gross profit	$	1,369.1		$	1,314.7		$	4,235.3		$	4,211.6


Gross margin		63.9	%		63.2	%		64.0	%		63.6	%
Inventory and manufacturing-related charges		0.6			0.3			0.8			0.4
Quality remediation		-			0.1			-			0.2
Intangible asset amortization		7.9			8.0			7.5			7.6
Adjusted gross margin		72.4	%		71.6	%		72.3	%		71.8	%

Page 21 of 24

ZIMMER BIOMET HOLDINGS, INC.
RECONCILIATION OF OPERATING PROFIT & MARGIN TO ADJUSTED OPERATING PROFIT & MARGIN
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2019 and 2018
(in millions, unaudited)


	Three Months Ended September 30,							Nine Months Ended September 30,
	2019				2018			2019				2018
Operating profit	$	245.8			$	223.3		$	800.7			$	824.3
Inventory and manufacturing-related charges		11.6				5.0			47.7				24.7
Intangible asset amortization		146.6				147.6			436.9				447.9
Intangible asset impairment		-				3.8			70.1				3.8
Acquisition, integration and related		(0.9	)			17.4			20.3				113.9
Quality remediation		21.5				34.2			64.6				125.8
Litigation		42.8				14.0			48.0				15.5
Litigation settlement gain		-				-			(23.5	)			-
European Union Medical Device Regulation		11.4				0.8			18.1				1.6
Other charges		22.2				24.9			88.3				46.8
Adjusted operating profit	$	501.0			$	471.0		$	1,571.2			$	1,604.3


Operating profit margin		13.0		%		12.2	%		13.7		%		14.1	%
Inventory and manufacturing-related charges		0.6				0.3			0.8				0.4
Intangible asset amortization		7.9				8.0			7.5				7.6
Intangible asset impairment		-				0.2			1.2				0.1
Acquisition, integration and related		-				0.9			0.3				1.9
Quality remediation		1.1				1.9			1.1				2.1
Litigation		2.3				0.8			0.8				0.3
Litigation settlement gain		-				-			(0.4	)			-
European Union Medical Device Regulation		0.6				-			0.3				-
Other charges		1.0				1.3			1.5				0.9
Adjusted operating profit margin		26.5		%		25.6	%		26.8		%		27.4	%

Page 22 of 24

ZIMMER BIOMET HOLDINGS, INC.
RECONCILIATION OF EFFECTIVE TAX RATE TO ADJUSTED EFFECTIVE TAX RATE
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2019 and 2018
(unaudited)


	Three Months Ended September 30,								Nine Months Ended September 30,
	2019				2018				2019				2018
Effective tax rate		(134.1	)	%		(5.5	)	%		(31.4	)	%		12.1	%
Inventory and manufacturing-related charges; intangible asset amortization; intangible asset impairment; acquisition, integration and related; quality remediation; litigation; litigation settlement gain; European Union Medical Device Regulation; other charges; Switzerland tax reform and other certain tax adjustments		150.6				22.0				48.6				6.5
Adjusted effective tax rate		16.5		%		16.5		%		17.2		%		18.6	%

Page 23 of 24

ZIMMER BIOMET HOLDINGS, INC.
RECONCILIATION OF DEBT TO NET DEBT
AS OF SEPTEMBER 30, 2019 and DECEMBER 31, 2018
(in millions, unaudited)


	September 30, 2019			December 31, 2018
Debt, both current and long-term	$	8,345.9		$	8,938.7
Cash and cash equivalents		(512.5	)		(542.8	)
Net debt	$	7,833.4		$	8,395.9

Page 24 of 24

Document and Entity Information	Nov. 05, 2019
Document Information [Line Items]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Nov. 05, 2019
Entity Registrant Name	ZIMMER BIOMET HOLDINGS, INC.
Entity Central Index Key	0001136869
Entity Emerging Growth Company	false
Entity File Number	001-16407
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	13-4151777
Entity Address, Address Line One	345 East Main Street
Entity Address, City or Town	Warsaw
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	46580
City Area Code	574
Local Phone Number	267-6131
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Common Stock [Member]
Document Information [Line Items]
Title of each class	Common Stock, $0.01 par value
Trading Symbol	ZBH
Name of each exchange on which registered	NYSE
1.414% Notes due 2022 [Member]
Document Information [Line Items]
Title of each class	1.414% Notes due 2022
Trading Symbol	ZBH 22A
Name of each exchange on which registered	NYSE
2.425% Notes due 2026 [Member]
Document Information [Line Items]
Title of each class	2.425% Notes due 2026
Trading Symbol	ZBH 26
Name of each exchange on which registered	NYSE

GRAPHIC 3 g1htqeri2fn2000001.jpg GRAPHIC begin 644 g1htqeri2fn2000001.jpg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end EX-101.SCH 4 zbh-20191105.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.DEF 5 zbh-20191105_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 6 zbh-20191105_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Information [Table] Document Information [Table] Class of Stock Statement Class Of Stock [Axis] Class of Stock Class Of Stock [Domain] Common Stock [Member] Common Stock [Member] One point four one four percentage notes due two thousand twenty two. 1.414% Notes due 2022 [Member] One Point Four One Four Percentage Notes Due Two Thousand Twenty Two [Member] Two point four two five percentage notes due two thousand twenty six. 2.425% Notes due 2026 [Member] Two Point Four Two Five Percentage Notes Due Two Thousand Twenty Six [Member] Document Information [Line Items] Document Information [Line Items] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Entity Emerging Growth Company Entity Emerging Growth Company Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre Commencement Tender Offer Pre-commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Title of each class Security12b Title Trading Symbol Trading Symbol Name of each exchange on which registered Security Exchange Name EX-101.PRE 7 zbh-20191105_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 10 0001564590-19-040046-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-19-040046-xbrl.zip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end XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 4 97 1 false 3 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports zbh-8k_20191105.htm zbh-20191105.xsd zbh-20191105_def.xml zbh-20191105_lab.xml zbh-20191105_pre.xml zbh-ex991_6.htm http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true false XML 12 zbh-8k_20191105_htm.xml IDEA: XBRL DOCUMENT 0001136869 2019-11-05 2019-11-05 0001136869 us-gaap:CommonStockMember 2019-11-05 2019-11-05 0001136869 zbh:OnePointFourOneFourPercentageNotesDueTwoThousandTwentyTwoMember 2019-11-05 2019-11-05 0001136869 zbh:TwoPointFourTwoFivePercentageNotesDueTwoThousandTwentySixMember 2019-11-05 2019-11-05 false 0001136869 8-K 2019-11-05 ZIMMER BIOMET HOLDINGS, INC. DE 001-16407 13-4151777 345 East Main Street Warsaw IN 46580 574 267-6131 false false false false Common Stock, $0.01 par value ZBH NYSE 1.414% Notes due 2022 ZBH 22A NYSE 2.425% Notes due 2026 ZBH 26 NYSE false EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 14 R1.htm IDEA: XBRL DOCUMENT v3.19.3

Document and Entity Information

Nov. 05, 2019

Document Information [Line Items]

Document Type 8-K

Amendment Flag false

Document Period End Date Nov. 05, 2019

Entity Registrant Name ZIMMER BIOMET HOLDINGS, INC.

Entity Central Index Key 0001136869

Entity Emerging Growth Company false

Entity File Number 001-16407

Entity Incorporation, State or Country Code DE

Entity Tax Identification Number 13-4151777

Entity Address, Address Line One 345 East Main Street

Entity Address, City or Town Warsaw

Entity Address, State or Province IN

Entity Address, Postal Zip Code 46580

City Area Code 574

Local Phone Number 267-6131

Written Communications false

Soliciting Material false

Pre-commencement Tender Offer false

Pre-commencement Issuer Tender Offer false

Common Stock [Member]

Document Information [Line Items]

Title of each class Common Stock, $0.01 par value

Trading Symbol ZBH

Name of each exchange on which registered NYSE

1.414% Notes due 2022 [Member]

Document Information [Line Items]

Title of each class 1.414% Notes due 2022

Trading Symbol ZBH 22A

Name of each exchange on which registered NYSE

2.425% Notes due 2026 [Member]

Document Information [Line Items]

Title of each class 2.425% Notes due 2026

Trading Symbol ZBH 26

Name of each exchange on which registered NYSE

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Area code of city
+ References
No definition available.
+ Details

Name: dei_CityAreaCode

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: dei_DocumentInformationLineItems

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details

Name: dei_EntityAddressAddressLine1

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the City or Town
+ References
No definition available.
+ Details

Name: dei_EntityAddressCityOrTown

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details

Name: dei_EntityAddressPostalZipCode

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the state or province.
+ References
No definition available.
+ Details

Name: dei_EntityAddressStateOrProvince

Namespace Prefix: dei_

Data Type: dei:stateOrProvinceItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityEmergingGrowthCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details

Name: dei_EntityFileNumber

Namespace Prefix: dei_

Data Type: dei:fileNumberItemType

Balance Type: na

Period Type: duration

X

- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details

Name: dei_EntityIncorporationStateCountryCode

Namespace Prefix: dei_

Data Type: dei:edgarStateCountryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityTaxIdentificationNumber

Namespace Prefix: dei_

Data Type: dei:employerIdItemType

Balance Type: na

Period Type: duration

X

- Definition
Local phone number for entity.
+ References
No definition available.
+ Details

Name: dei_LocalPhoneNumber

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details

Name: dei_PreCommencementIssuerTenderOffer

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details

Name: dei_PreCommencementTenderOffer

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details

Name: dei_Security12bTitle

Namespace Prefix: dei_

Data Type: dei:securityTitleItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details

Name: dei_SecurityExchangeName

Namespace Prefix: dei_

Data Type: dei:edgarExchangeCodeItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Section 14a
-Number 240
-Subsection 12
+ Details

Name: dei_SolicitingMaterial

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: dei:tradingSymbolItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details

Name: dei_WrittenCommunications

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=zbh_OnePointFourOneFourPercentageNotesDueTwoThousandTwentyTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=zbh_TwoPointFourTwoFivePercentageNotesDueTwoThousandTwentySixMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "zbh-8k_20191105.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 4, "dts": { "definitionLink": { "local": [ "zbh-20191105_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "zbh-8k_20191105.htm" ] }, "labelLink": { "local": [ "zbh-20191105_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "zbh-20191105_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "zbh-20191105.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "https://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 30, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 2, "memberStandard": 1, "nsprefix": "zbh", "nsuri": "http://www.zimmerbiomet.com/20191105", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "zbh-8k_20191105.htm", "contextRef": "C_0001136869_20191105_20191105", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "zbh-8k_20191105.htm", "contextRef": "C_0001136869_20191105_20191105", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 3, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "verboseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of each class" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Name of each exchange on which registered" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Class Of Stock [Domain]", "terseLabel": "Class of Stock" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement Class Of Stock [Axis]", "terseLabel": "Class of Stock" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "zbh_OnePointFourOneFourPercentageNotesDueTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "One point four one four percentage notes due two thousand twenty two.", "label": "One Point Four One Four Percentage Notes Due Two Thousand Twenty Two [Member]", "terseLabel": "1.414% Notes due 2022 [Member]" } } }, "localname": "OnePointFourOneFourPercentageNotesDueTwoThousandTwentyTwoMember", "nsuri": "http://www.zimmerbiomet.com/20191105", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "zbh_TwoPointFourTwoFivePercentageNotesDueTwoThousandTwentySixMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two point four two five percentage notes due two thousand twenty six.", "label": "Two Point Four Two Five Percentage Notes Due Two Thousand Twenty Six [Member]", "terseLabel": "2.425% Notes due 2026 [Member]" } } }, "localname": "TwoPointFourTwoFivePercentageNotesDueTwoThousandTwentySixMember", "nsuri": "http://www.zimmerbiomet.com/20191105", "presentation": [ "http://www.zimmerbiomet.com/20191105/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" }